reviewNature MedicineMay 1, 2007Closed access

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

Dynavax Technologies (United States)

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

860
total citations
FWCI
24.55
Percentile
100%
References
98
Citations per year

Authors

4

Topics & keywords

Keywords
  • Innate immune system
  • Toll-like receptor
  • Immunology
  • Receptor
  • Pattern recognition receptor
  • Immunity
  • Autoimmunity
  • Inflammation
No related works found for this paper.